Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02377830




Registration number
NCT02377830
Ethics application status
Date submitted
26/02/2015
Date registered
4/03/2015
Date last updated
5/12/2022

Titles & IDs
Public title
CYCLE Pilot Randomized Trial
Scientific title
CYCLE Pilot: A Pilot Randomized Study of Early Cycle Ergometry Versus Routine Physiotherapy in Mechanically Ventilated Patients
Secondary ID [1] 0 0
HIREB 14-531
Universal Trial Number (UTN)
Trial acronym
CYCLE Pilot
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Intensive Care Unit Acquired Weakness 0 0
Critical Care 0 0
Mechanical Ventilation 0 0
Respiratory Failure 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Routine physiotherapy

Experimental: Early Cycling and routine physiotherapy - Patients will receive 30 minutes of in-bed cycling in addition to routine physiotherapy, 5 days per week, for the duration of their ICU stay

Active comparator: Routine physiotherapy - Patients will receive routine physiotherapy per current institutional practice


Other interventions: Routine physiotherapy
activities to assist with optimizing airway clearance and respiratory function, and, based on the patient's alertness and medical stability, activities to maintain or increase limb range of motion and strength, in- and out of bed mobility, and ambulation
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Patient accrual
Timepoint [1] 0 0
2 years
Secondary outcome [1] 0 0
Cycling protocol violations (% cycling protocol violations)
Timepoint [1] 0 0
2 years
Secondary outcome [2] 0 0
Outcome measure ascertainment (% outcomes measured in hospital)
Timepoint [2] 0 0
2 years
Secondary outcome [3] 0 0
Blinded outcome measures at hospital discharge (% outcomes at hospital discharge measured by blinded outcome assessors)
Timepoint [3] 0 0
2 years
Secondary outcome [4] 0 0
Physical Function Test for ICU (PFIT) at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only) and hospital discharge
Timepoint [4] 0 0
From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Secondary outcome [5] 0 0
Muscle strength at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only), and hospital discharge
Timepoint [5] 0 0
From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Secondary outcome [6] 0 0
Quadriceps strength at ICU and hospital discharge (Force measured in Kg and in Newtons on a continuous scale)
Timepoint [6] 0 0
From study admission to approximately 12 and 30 days, on average, respectively
Secondary outcome [7] 0 0
2 minute walk test at ICU discharge, 3-days post-ICU (CYCLE Vanguard only), and hospital discharge
Timepoint [7] 0 0
From study admission to approximately 12 and 30 days, on average, respectively

Eligibility
Key inclusion criteria
* Adults admitted to a medical-surgical ICU within the 1st 4 days of mechanical ventilation (MV) and 1st 7 days of ICU, and
* could ambulate independently before hospital admission.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Acute condition impairing patients' ability to cycle (e.g., leg fracture),
* proven or suspected neuromuscular weakness affecting the legs (e.g., stroke or Guillain-Barré syndrome),
* unable to follow commands in English pre-ICU,
* temporary pacemaker,
* expected hospital mortality >90%,
* unable to fit the bike, palliative goals of care, or persistent therapy exemptions in the 1st 4 days of MV (e.g., cardiorespiratory instability, active major bleeding)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
Phase 2
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/03/2015
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/12/2018
Sample size
Target
Accrual to date
Final
113
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Austin Health - Melbourne
Recruitment postcode(s) [1] 0 0
3084 - Melbourne
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
North Carolina
Country [2] 0 0
Canada
State/province [2] 0 0
Ontario

Funding & Sponsors
Primary sponsor type
Other
Name
McMaster University
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
St. Joseph's Healthcare Hamilton
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
Hamilton Health Sciences Corporation
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
Technology Evaluation in the Elderly Network / Canadian Frailty Network
Address [3] 0 0
Country [3] 0 0
Other collaborator category [4] 0 0
Government body
Name [4] 0 0
Canadian Institutes of Health Research (CIHR)
Address [4] 0 0
Country [4] 0 0
Other collaborator category [5] 0 0
Other
Name [5] 0 0
Ontario Lung Association
Address [5] 0 0
Country [5] 0 0
Other collaborator category [6] 0 0
Other
Name [6] 0 0
Canadian Respiratory Research Network
Address [6] 0 0
Country [6] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Michelle Kho, PT, PhD
Address 0 0
McMaster University School of Rehabilitation Science
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

TypeCitations or Other Details
Journal Kho ME, Molloy AJ, Clarke FJ, Reid JC, Herridge MS... [More Details]

Results not provided in https://clinicaltrials.gov/study/NCT02377830